Search

everythinglearnresearchcommunity

for

Search:↓

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Finasteride causes harmful organ changes in female mice.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Father's finasteride use may affect son's fertility and testicular function.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Male pattern baldness involves hormones and cell signals affecting hair growth.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Laser treatment can stimulate hair growth for male pattern hair loss.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Minoxidil treatment increases aorta elasticity and reduces stiffness in aged mice, potentially helping with age-related heart issues.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.